Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte) after intrathecal administration in children with malignant brain tumors and leptomeningeal dissemination.

Trial Profile

Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte) after intrathecal administration in children with malignant brain tumors and leptomeningeal dissemination.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2015

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Brain cancer; Carcinomatous meningitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Oct 2013 Status changed from recruiting to completed according to results published in the Clinical Pharmacokinetics.
    • 11 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top